Centre For Translational Pathology Research And Training
Funder
National Health and Medical Research Council
Funding Amount
$2,677,639.00
Summary
The Centre for Translational Pathology Research and Training is a collaborative network involving nine hospitals and research institutes affiliated with The University of Melbourne. It's goal is train a cadre of molecular pathologists experienced in collaborative multidisciplinary research who can effective translate research discoveries and inventions in to clinically useful diagnostic tests that will enable oncologists to individualise treatment decisions for patients with cancer, based on the ....The Centre for Translational Pathology Research and Training is a collaborative network involving nine hospitals and research institutes affiliated with The University of Melbourne. It's goal is train a cadre of molecular pathologists experienced in collaborative multidisciplinary research who can effective translate research discoveries and inventions in to clinically useful diagnostic tests that will enable oncologists to individualise treatment decisions for patients with cancer, based on the unique biology of the individual's tumour.Read moreRead less
Using Chromosome Rearrangements As Tumour-specific Markers For Disease Monitoring In Lung Cancer Using Droplet Digital PCR
Funder
National Health and Medical Research Council
Funding Amount
$1,081,335.00
Summary
There are no useful markers apart from CT scans to determine the effectiveness of therapy in patients with lung cancer. We plan to assess highly sensitive methods that can examine the blood to determine whether DNA from the patient’s tumour is present. This will allow more responsive modulation of therapy to enable better management of the cancer.
Personalising Care In Operable Pancreas Cancer. GAP-T: A Study Of Imaging And Molecular Biomarkers To Guide Treatment Of Patients Receiving Preoperative Chemotherapy Followed By Surgery.
Funder
National Health and Medical Research Council
Funding Amount
$405,345.00
Summary
We are studying ways to improve how we treat patients with pancreatic cancer. We will use a novel imaging tool, the PET scanner, to show where active cancer is and how quickly and how well a new drug combination (gemcitabine and nab-paclitaxel) is affecting the cancer. We will also study if measuring the expression of specific proteins (SPARC and hENT1) in the cancer affects the outcome and will allow us to determine ahead of time which patients will benefit most from the drugs.
Translating Molecular Pathology Into Cancer Diagnostics
Funder
National Health and Medical Research Council
Funding Amount
$479,882.00
Summary
The aim of this research is focussed on translation of basic science through to the clinic by introducing novel cancer diagnostics and technologies. Other integral aims are to identify new changes in DNA and other cancer cell markers in patients, assess the clinical utility of these as biomarkers (surrogates of cancer behaviour) and to conduct novel clinical trials with newly identified molecular targets of cancer and new therapeutics and combinations to assess their efficacy.
Novel Therapeutic Strategies Targeting Aberrant Cell Cycle Regulation In Pancreatic Cancer And Development Of Robust Tissue-based Assay For Biomarkers Of Therapeutic Responsiveness
Funder
National Health and Medical Research Council
Funding Amount
$139,177.00
Summary
The overall aim of my research to assess noel therapeutic strategies in pancreatic cancer. Using new technology, more in depth understanding of pancreatic cancers (PC) is allowing better characterisation of these tumour into distinct molecular phenotypes. Some of these phenotypes are showing response to specific therapies in experimental models. Hence, there is an urgent need to to define these responsive phenotypes to stratify patients to appropriate therapeutic regimens.
The Role Of FHL Proteins In The Pathology Of Muscular Dystrophies: Identification Of Novel Therapeutic Targets
Funder
National Health and Medical Research Council
Funding Amount
$61,355.00
Summary
Scientists at Monash University have recently identified a protein called FHL1 which promotes skeletal muscle repair-growth and may reverse the muscle degeneration seen in inherited muscular dystrophies. This study will investigate whether FHL1 expression can improve muscle mass in mouse models of muscular dystropy. In doing so, this research improve out understanding of the molecular processes that cause muscular dystrophies and thereby lead the way to new therapies for this family of diseases.
The Role Chromatin Remodeling Factors In Epigenetic Regulation Of Cardiac Arrhythmia
Funder
National Health and Medical Research Council
Funding Amount
$854,135.00
Summary
Cardiovascular diseases kill an Australian every 11 minutes. Arrhythmias are of particular alarm since they can lead to significantly higher risk of serious strokes, heart failure, and overall mortality. We combine fruit fly genetics with next generation human genomics approaches to find and functionally validate new genes and mutations regulating arrhythmia in fruit flies and atrial fibrillation in humans, and this work can rapidly identify new avenues to pursue therapeutic intervention
Investigating a new paradigm for plant-pathogen interactions; Identification of host-selective toxin proteins in the wheat pathogen Stagonospora nodorum. Stagonospora nodorum is a fungus that causes leaf and glume blotch disease on wheat. This disease alone causes $55 million dollars in yield losses per annum. Traditional breeding methods have yielded crops that are only mildly resistant leaving control of the disease to be worryingly reliant on fungicides. This project aims to identify and char ....Investigating a new paradigm for plant-pathogen interactions; Identification of host-selective toxin proteins in the wheat pathogen Stagonospora nodorum. Stagonospora nodorum is a fungus that causes leaf and glume blotch disease on wheat. This disease alone causes $55 million dollars in yield losses per annum. Traditional breeding methods have yielded crops that are only mildly resistant leaving control of the disease to be worryingly reliant on fungicides. This project aims to identify and characterise proteins that the fungus secretes to cause disease on wheat. By identifying these proteins, it is anticipated that strategies, both traditional and modern, could be employed to enable better control of the disease. This in turn would help provide a long term and secure supply of wheat and wheat based products to the community.Read moreRead less
Risk Of Recurrence After Diagnosis Of Invasive Breast Cancer By Molecular Subtype As Defined By ER, PR And Her2 Status
Funder
National Health and Medical Research Council
Funding Amount
$500,622.00
Summary
Breast cancer is a heterogeneous disease. Molecular subtypes have been identified that differ in terms of prognosis and response to treatment. This study aims to estimate recurrence free survival of breast cancer by molecular subtypes in a population-based sample of Australian women. The results will assist clinicians to guide their therapeutic decisions and will inform women about their anticipated outcome after diagnosis of breast cancer.